Global Nanotechnology in Cancer Treatment Market Growth (Status and Outlook) 2020-2025
Apr, 2020
|
Report ID: 121911
|
118
|
Pharmaceuticals and Healthcare
According to this study, over the next five years the Nanotechnology in Cancer Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Nanotechnology in Cancer Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Nanotechnology in Cancer Treatment market by type, application, key companies and key regions.
This study considers the Nanotechnology in Cancer Treatment value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Nanoparticles
Nanorods
Nanofibers
Graphene
Metal-Organic Frameworks
Nanobiosensors
Nanofluidic Devices
Nanotools
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Cancer Detection
Imaging
Drug Delivery
Radiotherapy
Immunotherapy
Phototherapy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Celgene Corporation
Combimatrix Corporation
Sigma-Tau Pharmaceuticals Inc.
Johnson & Johnson
GE Healthcare
Nanosphere Inc.
Mallinckrodt Plc
Pfizer, Inc.
Merck & Company Inc.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nanotechnology in Cancer Treatment market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Nanotechnology in Cancer Treatment market by identifying its various subsegments.
Focuses on the key global Nanotechnology in Cancer Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nanotechnology in Cancer Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Nanotechnology in Cancer Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
This report presents a comprehensive overview, market shares and growth opportunities of Nanotechnology in Cancer Treatment market by type, application, key companies and key regions.
This study considers the Nanotechnology in Cancer Treatment value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Nanoparticles
Nanorods
Nanofibers
Graphene
Metal-Organic Frameworks
Nanobiosensors
Nanofluidic Devices
Nanotools
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Cancer Detection
Imaging
Drug Delivery
Radiotherapy
Immunotherapy
Phototherapy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Celgene Corporation
Combimatrix Corporation
Sigma-Tau Pharmaceuticals Inc.
Johnson & Johnson
GE Healthcare
Nanosphere Inc.
Mallinckrodt Plc
Pfizer, Inc.
Merck & Company Inc.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nanotechnology in Cancer Treatment market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Nanotechnology in Cancer Treatment market by identifying its various subsegments.
Focuses on the key global Nanotechnology in Cancer Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nanotechnology in Cancer Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Nanotechnology in Cancer Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanotechnology in Cancer Treatment Market Size 2015-2025
2.1.2 Nanotechnology in Cancer Treatment Market Size CAGR by Region
2.2 Nanotechnology in Cancer Treatment Segment by Type
2.2.1 Nanoparticles
2.2.2 Nanoparticles
2.2.3 Nanofibers
2.2.4 Graphene
2.2.5 Metal-Organic Frameworks
2.2.6 Nanobiosensors
2.2.7 Nanofluidic Devices
2.2.8 Nanotools
2.3 Nanotechnology in Cancer Treatment Market Size by Type
2.3.1 Global Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
2.3.2 Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Type (2015-2020)
2.4 Nanotechnology in Cancer Treatment Segment by Application
2.4.1 Cancer Detection
2.4.2 Imaging
2.4.3 Drug Delivery
2.4.4 Radiotherapy
2.4.5 Immunotherapy
2.4.6 Phototherapy
2.5 Nanotechnology in Cancer Treatment Market Size by Application
2.5.1 Global Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
2.5.2 Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Application (2015-2020)
3 Global Nanotechnology in Cancer Treatment by Players
3.1 Global Nanotechnology in Cancer Treatment Market Size Market Share by Players
3.1.1 Global Nanotechnology in Cancer Treatment Market Size by Players (2018-2020)
3.1.2 Global Nanotechnology in Cancer Treatment Market Size Market Share by Players (2018-2020)
3.2 Global Nanotechnology in Cancer Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nanotechnology in Cancer Treatment by Regions
4.1 Nanotechnology in Cancer Treatment Market Size by Regions
4.2 Americas Nanotechnology in Cancer Treatment Market Size Growth
4.3 APAC Nanotechnology in Cancer Treatment Market Size Growth
4.4 Europe Nanotechnology in Cancer Treatment Market Size Growth
4.5 Middle East & Africa Nanotechnology in Cancer Treatment Market Size Growth
5 Americas
5.1 Americas Nanotechnology in Cancer Treatment Market Size by Countries
5.2 Americas Nanotechnology in Cancer Treatment Market Size by Type
5.3 Americas Nanotechnology in Cancer Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Nanotechnology in Cancer Treatment Market Size by Regions
6.2 APAC Nanotechnology in Cancer Treatment Market Size by Type
6.3 APAC Nanotechnology in Cancer Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Nanotechnology in Cancer Treatment by Countries
7.2 Europe Nanotechnology in Cancer Treatment Market Size by Type
7.3 Europe Nanotechnology in Cancer Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Nanotechnology in Cancer Treatment by Countries
8.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type
8.3 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Nanotechnology in Cancer Treatment Market Forecast
10.1 Global Nanotechnology in Cancer Treatment Market Size Forecast (2021-2025)
10.2 Global Nanotechnology in Cancer Treatment Forecast by Regions
10.2.1 Global Nanotechnology in Cancer Treatment Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Nanotechnology in Cancer Treatment Forecast by Type
10.8 Global Nanotechnology in Cancer Treatment Forecast by Application
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Company Details
11.1.2 Nanotechnology in Cancer Treatment Product Offered
11.1.3 Abbott Laboratories Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Abbott Laboratories News
11.2 Celgene Corporation
11.2.1 Company Details
11.2.2 Nanotechnology in Cancer Treatment Product Offered
11.2.3 Celgene Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Celgene Corporation News
11.3 Combimatrix Corporation
11.3.1 Company Details
11.3.2 Nanotechnology in Cancer Treatment Product Offered
11.3.3 Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Combimatrix Corporation News
11.4 Sigma-Tau Pharmaceuticals Inc.
11.4.1 Company Details
11.4.2 Nanotechnology in Cancer Treatment Product Offered
11.4.3 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Sigma-Tau Pharmaceuticals Inc. News
11.5 Johnson & Johnson
11.5.1 Company Details
11.5.2 Nanotechnology in Cancer Treatment Product Offered
11.5.3 Johnson & Johnson Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Johnson & Johnson News
11.6 GE Healthcare
11.6.1 Company Details
11.6.2 Nanotechnology in Cancer Treatment Product Offered
11.6.3 GE Healthcare Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 GE Healthcare News
11.7 Nanosphere Inc.
11.7.1 Company Details
11.7.2 Nanotechnology in Cancer Treatment Product Offered
11.7.3 Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Nanosphere Inc. News
11.8 Mallinckrodt Plc
11.8.1 Company Details
11.8.2 Nanotechnology in Cancer Treatment Product Offered
11.8.3 Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Mallinckrodt Plc News
11.9 Pfizer, Inc.
11.9.1 Company Details
11.9.2 Nanotechnology in Cancer Treatment Product Offered
11.9.3 Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Pfizer, Inc. News
11.10 Merck & Company Inc.
11.10.1 Company Details
11.10.2 Nanotechnology in Cancer Treatment Product Offered
11.10.3 Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Merck & Company Inc. News
12 Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanotechnology in Cancer Treatment Market Size 2015-2025
2.1.2 Nanotechnology in Cancer Treatment Market Size CAGR by Region
2.2 Nanotechnology in Cancer Treatment Segment by Type
2.2.1 Nanoparticles
2.2.2 Nanoparticles
2.2.3 Nanofibers
2.2.4 Graphene
2.2.5 Metal-Organic Frameworks
2.2.6 Nanobiosensors
2.2.7 Nanofluidic Devices
2.2.8 Nanotools
2.3 Nanotechnology in Cancer Treatment Market Size by Type
2.3.1 Global Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
2.3.2 Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Type (2015-2020)
2.4 Nanotechnology in Cancer Treatment Segment by Application
2.4.1 Cancer Detection
2.4.2 Imaging
2.4.3 Drug Delivery
2.4.4 Radiotherapy
2.4.5 Immunotherapy
2.4.6 Phototherapy
2.5 Nanotechnology in Cancer Treatment Market Size by Application
2.5.1 Global Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
2.5.2 Global Nanotechnology in Cancer Treatment Market Size Growth Rate by Application (2015-2020)
3 Global Nanotechnology in Cancer Treatment by Players
3.1 Global Nanotechnology in Cancer Treatment Market Size Market Share by Players
3.1.1 Global Nanotechnology in Cancer Treatment Market Size by Players (2018-2020)
3.1.2 Global Nanotechnology in Cancer Treatment Market Size Market Share by Players (2018-2020)
3.2 Global Nanotechnology in Cancer Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nanotechnology in Cancer Treatment by Regions
4.1 Nanotechnology in Cancer Treatment Market Size by Regions
4.2 Americas Nanotechnology in Cancer Treatment Market Size Growth
4.3 APAC Nanotechnology in Cancer Treatment Market Size Growth
4.4 Europe Nanotechnology in Cancer Treatment Market Size Growth
4.5 Middle East & Africa Nanotechnology in Cancer Treatment Market Size Growth
5 Americas
5.1 Americas Nanotechnology in Cancer Treatment Market Size by Countries
5.2 Americas Nanotechnology in Cancer Treatment Market Size by Type
5.3 Americas Nanotechnology in Cancer Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Nanotechnology in Cancer Treatment Market Size by Regions
6.2 APAC Nanotechnology in Cancer Treatment Market Size by Type
6.3 APAC Nanotechnology in Cancer Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Nanotechnology in Cancer Treatment by Countries
7.2 Europe Nanotechnology in Cancer Treatment Market Size by Type
7.3 Europe Nanotechnology in Cancer Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Nanotechnology in Cancer Treatment by Countries
8.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type
8.3 Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Nanotechnology in Cancer Treatment Market Forecast
10.1 Global Nanotechnology in Cancer Treatment Market Size Forecast (2021-2025)
10.2 Global Nanotechnology in Cancer Treatment Forecast by Regions
10.2.1 Global Nanotechnology in Cancer Treatment Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Nanotechnology in Cancer Treatment Forecast by Type
10.8 Global Nanotechnology in Cancer Treatment Forecast by Application
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Company Details
11.1.2 Nanotechnology in Cancer Treatment Product Offered
11.1.3 Abbott Laboratories Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Abbott Laboratories News
11.2 Celgene Corporation
11.2.1 Company Details
11.2.2 Nanotechnology in Cancer Treatment Product Offered
11.2.3 Celgene Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Celgene Corporation News
11.3 Combimatrix Corporation
11.3.1 Company Details
11.3.2 Nanotechnology in Cancer Treatment Product Offered
11.3.3 Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Combimatrix Corporation News
11.4 Sigma-Tau Pharmaceuticals Inc.
11.4.1 Company Details
11.4.2 Nanotechnology in Cancer Treatment Product Offered
11.4.3 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Sigma-Tau Pharmaceuticals Inc. News
11.5 Johnson & Johnson
11.5.1 Company Details
11.5.2 Nanotechnology in Cancer Treatment Product Offered
11.5.3 Johnson & Johnson Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Johnson & Johnson News
11.6 GE Healthcare
11.6.1 Company Details
11.6.2 Nanotechnology in Cancer Treatment Product Offered
11.6.3 GE Healthcare Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 GE Healthcare News
11.7 Nanosphere Inc.
11.7.1 Company Details
11.7.2 Nanotechnology in Cancer Treatment Product Offered
11.7.3 Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Nanosphere Inc. News
11.8 Mallinckrodt Plc
11.8.1 Company Details
11.8.2 Nanotechnology in Cancer Treatment Product Offered
11.8.3 Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Mallinckrodt Plc News
11.9 Pfizer, Inc.
11.9.1 Company Details
11.9.2 Nanotechnology in Cancer Treatment Product Offered
11.9.3 Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Pfizer, Inc. News
11.10 Merck & Company Inc.
11.10.1 Company Details
11.10.2 Nanotechnology in Cancer Treatment Product Offered
11.10.3 Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Merck & Company Inc. News
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Nanotechnology in Cancer Treatment Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Nanoparticles
Table 5. Major Players of Nanorods
Table 6. Major Players of Nanofibers
Table 7. Major Players of Graphene
Table 8. Major Players of Metal-Organic Frameworks
Table 9. Major Players of Nanobiosensors
Table 10. Major Players of Nanofluidic Devices
Table 11. Major Players of Nanotools
Table 12. Nanotechnology in Cancer Treatment Market Size by Type (2014-2019) ($ Millions)
Table 13. Global Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 14. Global Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 15. Global Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 16. Global Nanotechnology in Cancer Treatment Revenue by Players (2018-2020) ($ Millions)
Table 17. Global Nanotechnology in Cancer Treatment Revenue Market Share by Players (2018-2020)
Table 18. Global Nanotechnology in Cancer Treatment Key Players Head office and Products Offered
Table 19. Nanotechnology in Cancer Treatment Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Nanotechnology in Cancer Treatment Market Size by Regions 2015-2020 ($ Millions)
Table 23. Global Nanotechnology in Cancer Treatment Market Size Market Share by Regions 2015-2020
Table 24. Americas Nanotechnology in Cancer Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 25. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Countries (2015-2020)
Table 26. Americas Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) ($ Millions)
Table 27. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 28. Americas Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 29. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 30. APAC Nanotechnology in Cancer Treatment Market Size by Regions (2015-2020) ($ Millions)
Table 31. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Regions (2015-2020)
Table 32. APAC Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) ($ Millions)
Table 33. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 34. APAC Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 35. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 36. Europe Nanotechnology in Cancer Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 37. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Countries (2015-2020)
Table 38. Europe Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) ($ Millions)
Table 39. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 40. Europe Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 41. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 42. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 43. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) ($ Millions)
Table 45. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 46. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 47. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 48. Key and Potential Regions of Nanotechnology in Cancer Treatment
Table 49. Key Application and Potential Industries of Nanotechnology in Cancer Treatment
Table 50. Key Challenges of Nanotechnology in Cancer Treatment
Table 51. Key Trends of Nanotechnology in Cancer Treatment
Table 52. Global Nanotechnology in Cancer Treatment Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 53. Global Nanotechnology in Cancer Treatment Market Size Market Share Forecast by Regions
Table 54. Global Nanotechnology in Cancer Treatment Market Size Forecast by Type (2021-2025) ($ Millions)
Table 55. Global Nanotechnology in Cancer Treatment Market Size Market Share Forecast by Type (2021-2025)
Table 56. Global Nanotechnology in Cancer Treatment Market Size Forecast by Application (2021-2025) ($ Millions)
Table 57. Global Nanotechnology in Cancer Treatment Market Size Market Share Forecast by Application (2021-2025)
Table 58. Abbott Laboratories Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 59. Abbott Laboratories Nanotechnology in Cancer Treatment Product Offered
Table 60. Abbott Laboratories Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 61. Abbott Laboratories Main Business
Table 62. Abbott Laboratories Latest Developments
Table 63. Celgene Corporation Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 64. Celgene Corporation Nanotechnology in Cancer Treatment Product Offered
Table 65. Celgene Corporation Main Business
Table 66. Celgene Corporation Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 67. Celgene Corporation Latest Developments
Table 68. Combimatrix Corporation Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 69. Combimatrix Corporation Nanotechnology in Cancer Treatment Product Offered
Table 70. Combimatrix Corporation Main Business
Table 71. Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 72. Combimatrix Corporation Latest Developments
Table 73. Sigma-Tau Pharmaceuticals Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 74. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Product Offered
Table 75. Sigma-Tau Pharmaceuticals Inc. Main Business
Table 76. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 77. Sigma-Tau Pharmaceuticals Inc. Latest Developments
Table 78. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 79. Johnson & Johnson Nanotechnology in Cancer Treatment Product Offered
Table 80. Johnson & Johnson Main Business
Table 81. Johnson & Johnson Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 82. Johnson & Johnson Latest Developments
Table 83. GE Healthcare Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 84. GE Healthcare Nanotechnology in Cancer Treatment Product Offered
Table 85. GE Healthcare Main Business
Table 86. GE Healthcare Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 87. GE Healthcare Latest Developments
Table 88. Nanosphere Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 89. Nanosphere Inc. Nanotechnology in Cancer Treatment Product Offered
Table 90. Nanosphere Inc. Main Business
Table 91. Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 92. Nanosphere Inc. Latest Developments
Table 93. Mallinckrodt Plc Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 94. Mallinckrodt Plc Nanotechnology in Cancer Treatment Product Offered
Table 95. Mallinckrodt Plc Main Business
Table 96. Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 97. Mallinckrodt Plc Latest Developments
Table 98. Pfizer, Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 99. Pfizer, Inc. Nanotechnology in Cancer Treatment Product Offered
Table 100. Pfizer, Inc. Main Business
Table 101. Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 102. Pfizer, Inc. Latest Developments
Table 103. Merck & Company Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 104. Merck & Company Inc. Nanotechnology in Cancer Treatment Product Offered
Table 105. Merck & Company Inc. Main Business
Table 106. Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 107. Merck & Company Inc. Latest Developments
List of Figures
Figure 1. Nanotechnology in Cancer Treatment Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Nanotechnology in Cancer Treatment Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Figure 5. Global Nanoparticles Market Size Growth Rate
Figure 6. Global Nanorods Market Size Growth Rate
Figure 7. Global Nanofibers Market Size Growth Rate
Figure 8. Global Graphene Market Size Growth Rate
Figure 9. Global Metal-Organic Frameworks Market Size Growth Rate
Figure 10. Global Nanobiosensors Market Size Growth Rate
Figure 11. Global Nanofluidic Devices Market Size Growth Rate
Figure 12. Global Nanotools Market Size Growth Rate
Figure 13. Nanotechnology in Cancer Treatment in Cancer Detection
Figure 14. Global Nanotechnology in Cancer Treatment Market: Cancer Detection (2015-2020) ($ Millions)
Figure 15. Nanotechnology in Cancer Treatment in Imaging
Figure 16. Global Nanotechnology in Cancer Treatment Market: Imaging (2015-2020) ($ Millions)
Figure 17. Nanotechnology in Cancer Treatment in Drug Delivery
Figure 18. Global Nanotechnology in Cancer Treatment Market: Drug Delivery (2015-2020) ($ Millions)
Figure 19. Global Drug Delivery YoY Growth ($ Millions)
Figure 20. Nanotechnology in Cancer Treatment in Radiotherapy
Figure 21. Global Nanotechnology in Cancer Treatment Market: Radiotherapy (2015-2020) ($ Millions)
Figure 22. Global Radiotherapy YoY Growth ($ Millions)
Figure 23. Nanotechnology in Cancer Treatment in Immunotherapy
Figure 24. Global Nanotechnology in Cancer Treatment Market: Immunotherapy (2015-2020) ($ Millions)
Figure 25. Global Immunotherapy YoY Growth ($ Millions)
Figure 26. Global Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 27. Global Nanotechnology in Cancer Treatment Market Size Market Share by Regions 2015-2020
Figure 28. Americas Nanotechnology in Cancer Treatment Market Size 2015-2020 ($ Millions)
Figure 29. APAC Nanotechnology in Cancer Treatment Market Size 2015-2020 ($ Millions)
Figure 30. Europe Nanotechnology in Cancer Treatment Market Size 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Nanotechnology in Cancer Treatment Market Size 2015-2020 ($ Millions)
Figure 32. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Countries in 2019
Figure 33. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Type in 2019
Figure 34. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 35. United States Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 36. Canada Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 37. Mexico Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 38. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Regions in 2019
Figure 39. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Type in 2019
Figure 40. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 41. China Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 42. Japan Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 43. Korea Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 44. Southeast Asia Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 45. India Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 46. Australia Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 47. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Countries in 2019
Figure 48. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Type in 2019
Figure 49. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 50. Germany Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 51. France Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 52. UK Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 53. Italy Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 54. Russia Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 55. Spain Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 56. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Countries in 2019
Figure 57. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Type in 2019
Figure 58. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 59. Egypt Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 60. South Africa Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 61. Israel Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 62. Turkey Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 63. GCC Countries Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 64. Global Nanotechnology in Cancer Treatment arket Size Forecast (2021-2025) ($ Millions)
Figure 65. Americas Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 66. APAC Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 67. Europe Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 68. Middle East & Africa Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 69. United States Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 70. Canada Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 71. Mexico Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 72. Brazil Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 73. China Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 74. Japan Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 75. Korea Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 76. Southeast Asia Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 77. India Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 78. Australia Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 79. Germany Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 80. France Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 81. UK Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 82. Italy Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 83. Russia Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 84. Spain Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 85. Egypt Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 86. South Africa Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 87. Israel Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 88. Turkey Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 89. GCC Countries Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Table 1. Research Methodology
Table 2. Data Source
Table 3. Nanotechnology in Cancer Treatment Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Nanoparticles
Table 5. Major Players of Nanorods
Table 6. Major Players of Nanofibers
Table 7. Major Players of Graphene
Table 8. Major Players of Metal-Organic Frameworks
Table 9. Major Players of Nanobiosensors
Table 10. Major Players of Nanofluidic Devices
Table 11. Major Players of Nanotools
Table 12. Nanotechnology in Cancer Treatment Market Size by Type (2014-2019) ($ Millions)
Table 13. Global Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 14. Global Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 15. Global Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 16. Global Nanotechnology in Cancer Treatment Revenue by Players (2018-2020) ($ Millions)
Table 17. Global Nanotechnology in Cancer Treatment Revenue Market Share by Players (2018-2020)
Table 18. Global Nanotechnology in Cancer Treatment Key Players Head office and Products Offered
Table 19. Nanotechnology in Cancer Treatment Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Nanotechnology in Cancer Treatment Market Size by Regions 2015-2020 ($ Millions)
Table 23. Global Nanotechnology in Cancer Treatment Market Size Market Share by Regions 2015-2020
Table 24. Americas Nanotechnology in Cancer Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 25. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Countries (2015-2020)
Table 26. Americas Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) ($ Millions)
Table 27. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 28. Americas Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 29. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 30. APAC Nanotechnology in Cancer Treatment Market Size by Regions (2015-2020) ($ Millions)
Table 31. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Regions (2015-2020)
Table 32. APAC Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) ($ Millions)
Table 33. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 34. APAC Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 35. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 36. Europe Nanotechnology in Cancer Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 37. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Countries (2015-2020)
Table 38. Europe Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) ($ Millions)
Table 39. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 40. Europe Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 41. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 42. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 43. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Countries (2015-2020)
Table 44. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Type (2015-2020) ($ Millions)
Table 45. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Table 46. Middle East & Africa Nanotechnology in Cancer Treatment Market Size by Application (2015-2020) ($ Millions)
Table 47. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Application (2015-2020)
Table 48. Key and Potential Regions of Nanotechnology in Cancer Treatment
Table 49. Key Application and Potential Industries of Nanotechnology in Cancer Treatment
Table 50. Key Challenges of Nanotechnology in Cancer Treatment
Table 51. Key Trends of Nanotechnology in Cancer Treatment
Table 52. Global Nanotechnology in Cancer Treatment Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 53. Global Nanotechnology in Cancer Treatment Market Size Market Share Forecast by Regions
Table 54. Global Nanotechnology in Cancer Treatment Market Size Forecast by Type (2021-2025) ($ Millions)
Table 55. Global Nanotechnology in Cancer Treatment Market Size Market Share Forecast by Type (2021-2025)
Table 56. Global Nanotechnology in Cancer Treatment Market Size Forecast by Application (2021-2025) ($ Millions)
Table 57. Global Nanotechnology in Cancer Treatment Market Size Market Share Forecast by Application (2021-2025)
Table 58. Abbott Laboratories Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 59. Abbott Laboratories Nanotechnology in Cancer Treatment Product Offered
Table 60. Abbott Laboratories Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 61. Abbott Laboratories Main Business
Table 62. Abbott Laboratories Latest Developments
Table 63. Celgene Corporation Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 64. Celgene Corporation Nanotechnology in Cancer Treatment Product Offered
Table 65. Celgene Corporation Main Business
Table 66. Celgene Corporation Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 67. Celgene Corporation Latest Developments
Table 68. Combimatrix Corporation Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 69. Combimatrix Corporation Nanotechnology in Cancer Treatment Product Offered
Table 70. Combimatrix Corporation Main Business
Table 71. Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 72. Combimatrix Corporation Latest Developments
Table 73. Sigma-Tau Pharmaceuticals Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 74. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Product Offered
Table 75. Sigma-Tau Pharmaceuticals Inc. Main Business
Table 76. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 77. Sigma-Tau Pharmaceuticals Inc. Latest Developments
Table 78. Johnson & Johnson Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 79. Johnson & Johnson Nanotechnology in Cancer Treatment Product Offered
Table 80. Johnson & Johnson Main Business
Table 81. Johnson & Johnson Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 82. Johnson & Johnson Latest Developments
Table 83. GE Healthcare Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 84. GE Healthcare Nanotechnology in Cancer Treatment Product Offered
Table 85. GE Healthcare Main Business
Table 86. GE Healthcare Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 87. GE Healthcare Latest Developments
Table 88. Nanosphere Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 89. Nanosphere Inc. Nanotechnology in Cancer Treatment Product Offered
Table 90. Nanosphere Inc. Main Business
Table 91. Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 92. Nanosphere Inc. Latest Developments
Table 93. Mallinckrodt Plc Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 94. Mallinckrodt Plc Nanotechnology in Cancer Treatment Product Offered
Table 95. Mallinckrodt Plc Main Business
Table 96. Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 97. Mallinckrodt Plc Latest Developments
Table 98. Pfizer, Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 99. Pfizer, Inc. Nanotechnology in Cancer Treatment Product Offered
Table 100. Pfizer, Inc. Main Business
Table 101. Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 102. Pfizer, Inc. Latest Developments
Table 103. Merck & Company Inc. Details, Company Total Revenue (in $ million), Head Office, Nanotechnology in Cancer Treatment Major Market Areas and Its Competitors
Table 104. Merck & Company Inc. Nanotechnology in Cancer Treatment Product Offered
Table 105. Merck & Company Inc. Main Business
Table 106. Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue and Gross Margin (2018-2020E)
Table 107. Merck & Company Inc. Latest Developments
List of Figures
Figure 1. Nanotechnology in Cancer Treatment Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Nanotechnology in Cancer Treatment Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Nanotechnology in Cancer Treatment Market Size Market Share by Type (2015-2020)
Figure 5. Global Nanoparticles Market Size Growth Rate
Figure 6. Global Nanorods Market Size Growth Rate
Figure 7. Global Nanofibers Market Size Growth Rate
Figure 8. Global Graphene Market Size Growth Rate
Figure 9. Global Metal-Organic Frameworks Market Size Growth Rate
Figure 10. Global Nanobiosensors Market Size Growth Rate
Figure 11. Global Nanofluidic Devices Market Size Growth Rate
Figure 12. Global Nanotools Market Size Growth Rate
Figure 13. Nanotechnology in Cancer Treatment in Cancer Detection
Figure 14. Global Nanotechnology in Cancer Treatment Market: Cancer Detection (2015-2020) ($ Millions)
Figure 15. Nanotechnology in Cancer Treatment in Imaging
Figure 16. Global Nanotechnology in Cancer Treatment Market: Imaging (2015-2020) ($ Millions)
Figure 17. Nanotechnology in Cancer Treatment in Drug Delivery
Figure 18. Global Nanotechnology in Cancer Treatment Market: Drug Delivery (2015-2020) ($ Millions)
Figure 19. Global Drug Delivery YoY Growth ($ Millions)
Figure 20. Nanotechnology in Cancer Treatment in Radiotherapy
Figure 21. Global Nanotechnology in Cancer Treatment Market: Radiotherapy (2015-2020) ($ Millions)
Figure 22. Global Radiotherapy YoY Growth ($ Millions)
Figure 23. Nanotechnology in Cancer Treatment in Immunotherapy
Figure 24. Global Nanotechnology in Cancer Treatment Market: Immunotherapy (2015-2020) ($ Millions)
Figure 25. Global Immunotherapy YoY Growth ($ Millions)
Figure 26. Global Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 27. Global Nanotechnology in Cancer Treatment Market Size Market Share by Regions 2015-2020
Figure 28. Americas Nanotechnology in Cancer Treatment Market Size 2015-2020 ($ Millions)
Figure 29. APAC Nanotechnology in Cancer Treatment Market Size 2015-2020 ($ Millions)
Figure 30. Europe Nanotechnology in Cancer Treatment Market Size 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Nanotechnology in Cancer Treatment Market Size 2015-2020 ($ Millions)
Figure 32. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Countries in 2019
Figure 33. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Type in 2019
Figure 34. Americas Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 35. United States Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 36. Canada Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 37. Mexico Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 38. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Regions in 2019
Figure 39. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Type in 2019
Figure 40. APAC Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 41. China Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 42. Japan Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 43. Korea Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 44. Southeast Asia Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 45. India Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 46. Australia Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 47. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Countries in 2019
Figure 48. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Type in 2019
Figure 49. Europe Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 50. Germany Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 51. France Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 52. UK Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 53. Italy Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 54. Russia Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 55. Spain Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 56. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Countries in 2019
Figure 57. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Type in 2019
Figure 58. Middle East & Africa Nanotechnology in Cancer Treatment Market Size Market Share by Application in 2019
Figure 59. Egypt Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 60. South Africa Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 61. Israel Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 62. Turkey Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 63. GCC Countries Nanotechnology in Cancer Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 64. Global Nanotechnology in Cancer Treatment arket Size Forecast (2021-2025) ($ Millions)
Figure 65. Americas Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 66. APAC Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 67. Europe Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 68. Middle East & Africa Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 69. United States Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 70. Canada Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 71. Mexico Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 72. Brazil Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 73. China Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 74. Japan Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 75. Korea Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 76. Southeast Asia Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 77. India Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 78. Australia Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 79. Germany Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 80. France Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 81. UK Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 82. Italy Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 83. Russia Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 84. Spain Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 85. Egypt Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 86. South Africa Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 87. Israel Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 88. Turkey Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
Figure 89. GCC Countries Nanotechnology in Cancer Treatment Market Size 2021-2025 ($ Millions)
